Live Breaking News & Updates on Duarte California

Stay updated with breaking news from Duarte california. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Liso-Cel Leads to Rapid Responses, High Undetectable MRD Rates in Relapsed/Refractory CLL/SLL

Treatment with lisocabtagene maraleucel elicited encouraging responses regardless of prior progression on BTK inhibition or absence of clinical benefit with venetoclax in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma, meeting the primary end point of the phase 1/2 TRANSCEND CLL 004 trial. ....

Tanya Siddiqi , Toni Stephenson Lymphoma Center , International Workshop , Division Of Lymphoma , Hope Orange County , Duarte California , Chronic Lymphocytic Leukemia , Department Of Hematology , Hematopoietic Cell Transplantation , Asco Annual Meeting ,

Nouscom Announces Positive Full Phase 1 Data of NOUS-209, an 'off-the-shelf' Neoantigen Cancer Immunotherapy for the Treatment of dMMR/MSI-H Solid Tumors, at ASCO 2022

/PRNewswire/ Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized viral vectored immunotherapies, today announced. ....

United States , Eleanor Perkin , Prnewswire Nouscom , Rick Davis , Marwang Fakih , Sylvie Berrebi , Marina Udier , American Association For Cancer Research , American Society Of Clinical Oncology , Clinical Oncology , Annual Meeting , Microsatellite Instable High , American Association , Cancer Research , Medical Oncology Specialist , Duarte California , Chief Executive Officer , Presentation Details , Microsatellite Instability , Professor Marwan , Great Ape Adenoviral , Modified Vaccinia Ankara ,

Nouscom to Present Full Phase 1 Data of NOUS-209, an 'off-the-shelf' Neoantigen Cancer Immunotherapy for the Treatment of dMMR/MSI-H Solid Tumors, at ASCO 2022

/PRNewswire/ Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized viral vectored immunotherapies, today announced. ....

United States , Marwan Fakih , Eleanor Perkin , Rick Davis , Sylvie Berrebi , American Society Of Clinical Oncology , Clinical Oncology , Microsatellite Instable High , Presentation Details , Medical Oncology Specialist , Duarte California , Great Ape Adenoviral , Modified Vaccinia Ankara ,

New Data of Cancer Vaccine for Solid Tumors

Nouscom today announced encouraging new translational data obtained from the ongoing Phase 1 trial evaluating NOUS-209. The data were presented yesterday ....

United States , Marwang Fakih , Elisa Scarselli , American Association For Cancer Research , Society For Immunotherapy Of Cancer , Late Breaking , Cancer Research , Microsatellite Instable High , Annual Meeting , Medical Oncology Specialist , Duarte California , Chief Scientific Officer ,

Nouscom Announces New Translational Phase 1 Data of NOUS-209, an 'off-the-shelf' Neoantigen Cancer Vaccine for the Treatment of MSI-H Solid Tumors, at

BASEL, Switzerland – 11th April 2022 - Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized viral vectored immunotherapies, today announced encouraging new translational data obtained from the ongoing Phase 1 trial evaluating NOUS-209. The data were presented yesterday in. ....

United States , Marwang Fakih , Elisa Scarselli , American Association For Cancer Research , Society For Immunotherapy Of Cancer , Late Breaking , Cancer Research , Microsatellite Instable High , Annual Meeting , Medical Oncology Specialist , Duarte California , Chief Scientific Officer ,